phenylpropanolamine has been researched along with Body Weight in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (52.63) | 18.7374 |
| 1990's | 9 (23.68) | 18.2507 |
| 2000's | 4 (10.53) | 29.6817 |
| 2010's | 5 (13.16) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blüher, M; Chen-Stute, A; Hastreiter, L; Hauner, H; Scholze, J; Werdier, D | 1 |
| Chen, PN; Hsieh, YS; Kuo, DY; Liao, JM; Yu, CH | 1 |
| Chen, PN; Hsieh, YS; Kuo, DY | 1 |
| Chen, PN; Chu, SC; Hsieh, YS; Kuo, DY; Yu, CH | 1 |
| Byron, JK; Phillips, GS; Stahl, MS; Taylor, KH | 1 |
| Borgstein, NG; Djurhuus, JC; Ellsworth, P; Nijman, RJ | 1 |
| Chu, SC; Hsieh, YS; Kuo, DY; Yang, SF | 2 |
| Chiou, HL; Hsieh, YS; Kuo, DY; Yang, SF | 1 |
| Altschuler, S; Conte, A; Marlin, RL; Sebok, M; Winick, C | 1 |
| Issmeier, G; Muth, H | 1 |
| Peters, RH; Wellman, PJ | 1 |
| Brancato, DA; Cohen, BI; Fow, MI | 1 |
| Carlini, EA; Zelger, JL | 1 |
| DeBon, M; Isbell, TR; Klem, ML; Klesges, LM; Klesges, RC; Shelton, ML | 1 |
| Amos, JC; Coday, MC; Dykstra, T; Rushing, PA; Wilson, MR; Winders, SE | 1 |
| Mittleman, G; Rushing, PA; Winders, SE | 1 |
| Fraioli, S; Nencini, P; Perrella, D | 1 |
| Klesges, RC; Rushing, PA; Watson, SL; Winders, SE | 1 |
| Hoebel, BG | 2 |
| Amos, JC; Coday, MC; Dykstra, T; Wilkins, DR; Wilson, MR; Winders, SE | 1 |
| Bulik, CM | 1 |
| Krueger, WF; Oyawoye, EO | 1 |
| Isbell, T; Klem, ML; Klesges, LM; Klesges, RC; Meyers, AW | 1 |
| Blackburn, GL; Funderburk, FR; Morgan, JP; Noble, R | 1 |
| Blackburn, GL; Funderburk, FR; Istfan, N; Lavin, PT; Morgan, JP; Noble, R | 1 |
| Barker, E; Martinez, TT | 1 |
| Noble, R | 1 |
| Miller, J; Wellman, PJ | 1 |
| Byrne, LM; Ginsberg, G; O'Connor, P; Schuster, B; Stein, EC; Sundaresan, PR; Weintraub, M | 1 |
| Silverstone, T | 1 |
| Jansson, T; Kristiansson, B; Qirbi, A | 1 |
| Jessen, TG; Martinez, TT | 1 |
| Kutscher, CL | 1 |
| Sellers, TL; Wellman, PJ | 1 |
| Byrne, L; Cox, C; Moscucci, M; Weintraub, M | 1 |
| Marmon, MM; Wellman, PJ | 1 |
3 review(s) available for phenylpropanolamine and Body Weight
| Article | Year |
|---|---|
Hypothalamic self-stimulation and stimulation escape in relation to feeding and mating.
Topics: Animals; Body Weight; Brain Mapping; Electric Stimulation; Feeding Behavior; Female; Hydroxydopamines; Hypothalamus; Male; Neural Pathways; Phenylpropanolamine; Rats; Reinforcement, Psychology; Self Stimulation; Sexual Behavior, Animal; Stimulation, Chemical; Sympathetic Nervous System | 1979 |
Abuse of drugs associated with eating disorders.
Topics: Adult; Animals; Anorexia Nervosa; Appetite; Body Weight; Bulimia; Cathartics; Diuretics; Emetics; Female; Humans; Phenylpropanolamine; Risk Factors; Substance-Related Disorders | 1992 |
Clinical use of appetite suppressants.
Topics: Amphetamines; Appetite Depressants; Body Weight; Diethylpropion; Double-Blind Method; Drug Tolerance; Eating; Fenfluramine; Humans; Hunger; Mazindol; Obesity; Phenmetrazine; Phentermine; Phenylpropanolamine | 1986 |
11 trial(s) available for phenylpropanolamine and Body Weight
| Article | Year |
|---|---|
Efficacy and Safety of Cathine (Nor-Pseudoephedrine) in the Treatment of Obesity: A Randomized Dose-Finding Study.
Topics: Adult; Anti-Obesity Agents; Body Mass Index; Body Weight; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Obesity; Overweight; Phenylpropanolamine; Placebos; Weight Loss | 2017 |
Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
Topics: Benzhydryl Compounds; Body Weight; Child; Child, Preschool; Circadian Rhythm; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Placebo Effect; Placebos; Safety; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Incontinence; Urination | 2005 |
Three controlled trials of weight loss with phenylpropanolamine.
Topics: Adolescent; Adult; Appetite Depressants; Blood Pressure; Body Weight; Caffeine; Clinical Trials as Topic; Diethylpropion; Double-Blind Method; Drug Combinations; Humans; Mazindol; Middle Aged; Obesity; Phenylpropanolamine; Pulse | 1982 |
[Weight loss by treatment with Fugoa depot. Results of a double blind study].
Topics: Aged; Body Weight; Clinical Trials as Topic; Double-Blind Method; Ephedrine; Female; Humans; Male; Middle Aged; Obesity; Phenylpropanolamine; Stereoisomerism | 1980 |
Effects of phenylpropanolamine on withdrawal symptoms.
Topics: Adult; Blood Pressure; Body Weight; Female; Humans; Male; Phenylpropanolamine; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Acute administration of phenylpropanolamine fails to affect resting energy expenditure in men of normal weight.
Topics: Adolescent; Adult; Appetite Depressants; Blood Pressure; Body Weight; Calorimetry, Indirect; Energy Metabolism; Humans; Male; Oxygen Consumption; Phenylpropanolamine; Placebos | 1997 |
The effects of phenylpropanolamine on dietary intake, physical activity, and body weight after smoking cessation.
Topics: Adult; Blood Pressure; Body Weight; Eating; Exercise; Female; Gingiva; Heart Rate; Humans; Phenylpropanolamine; Smoking Prevention | 1990 |
Subjective profile of phenylpropanolamine: absence of stimulant or euphorigenic effects at recommended dose levels.
Topics: Adolescent; Adult; Appetite; Arousal; Body Weight; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Humans; Middle Aged; Phenylpropanolamine | 1989 |
Determinants of the pressor effect of phenylpropanolamine in healthy subjects.
Topics: Adolescent; Adult; Aged; Blood Pressure; Body Weight; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenylpropanolamine; Posture; Random Allocation; Time Factors | 1989 |
A controlled clinical trial of the cardiovascular and psychological effects of phenylpropanolamine and caffeine.
Topics: Adult; Behavior; Blood Pressure; Body Weight; Caffeine; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Male; Phenylpropanolamine; Random Allocation | 1988 |
Phenylpropanolamine OROS (Acutrim) vs. placebo in combination with caloric restriction and physician-managed behavior modification.
Topics: Adolescent; Adult; Behavior Therapy; Blood Pressure; Body Weight; Clinical Trials as Topic; Counseling; Delayed-Action Preparations; Diet, Reducing; Double-Blind Method; Drug Evaluation; Female; Humans; Obesity; Patient Compliance; Phenylpropanolamine; Physical Exertion; Pulse | 1986 |
24 other study(ies) available for phenylpropanolamine and Body Weight
| Article | Year |
|---|---|
Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NF-κB-mediated feeding behavior in phenylpropanolamine-treated rats.
Topics: Animals; Antisense Elements (Genetics); Appetite Depressants; Blotting, Western; Body Weight; Catheterization; Cerebral Ventricles; Feeding Behavior; Hypothalamus; Inferior Colliculi; Injections; Male; NF-kappa B; Phenylpropanolamine; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Melanocortin; Receptors, Neuropeptide Y | 2013 |
Targeting oxidative stress in the hypothalamus: the effect of transcription factor STAT3 knockdown on endogenous antioxidants-mediated appetite control.
Topics: Animals; Antioxidants; Appetite Depressants; Blotting, Western; Body Weight; Eating; Electrophoresis, Agar Gel; Hypothalamus; Janus Kinase 2; Male; Neuropeptide Y; Oxidative Stress; Phenylpropanolamine; Pro-Opiomelanocortin; Rats, Wistar; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor | 2015 |
Mediation of oxidative stress in hypothalamic ghrelin-associated appetite control in rats treated with phenylpropanolamine.
Topics: Animals; Anorexia; Appetite; Body Weight; Eating; Feeding Behavior; Ghrelin; Hypothalamus; Male; Neuropeptide Y; Oxidative Stress; Peptide Hormones; Phenylpropanolamine; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Ghrelin | 2017 |
Urethral Sphincter Mechanism Incompetence in 163 Neutered Female Dogs: Diagnosis, Treatment, and Relationship of Weight and Age at Neuter to Development of Disease.
Topics: Age Factors; Animals; Body Weight; Diethylstilbestrol; Dog Diseases; Dogs; Female; Ovariectomy; Phenylpropanolamine; Retrospective Studies; Urethral Diseases; Urinary Incontinence | 2017 |
Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
Topics: Animals; Anorexia; Appetite Depressants; Body Weight; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Feeding Behavior; Gene Expression Regulation; Gene Targeting; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Oligodeoxyribonucleotides, Antisense; Phenylpropanolamine; Pro-Opiomelanocortin; Protein Biosynthesis; Rats; RNA, Messenger; Transcription, Genetic | 2007 |
Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine.
Topics: Analysis of Variance; Animals; Appetite Depressants; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Feeding Behavior; Gene Expression Regulation; Hypothalamus; Male; Nerve Tissue Proteins; Neuropeptide Y; Phenylpropanolamine; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Transcription Factor AP-1 | 2008 |
Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Bupropion; Catecholamines; Catheterization; Central Nervous System; Dopamine Uptake Inhibitors; Drug Tolerance; Electrophoresis, Polyacrylamide Gel; Feeding Behavior; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Oligonucleotides, Antisense; Phenylpropanolamine; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2007 |
Effects of amphetamine and phenylpropanolamine on food intake in rats with ventromedial hypothalamic or dorsolateral tegmental damage.
Topics: Animals; Body Weight; Dextroamphetamine; Diet; Dietary Fats; Feeding Behavior; Female; Hypothalamus; Phenylpropanolamine; Rats; Tegmentum Mesencephali | 1980 |
Phenylpropanolamine weight control products.
Topics: Body Weight; Humans; Phenylpropanolamine; Poisoning; United States | 1981 |
Anorexigenic effects of two amines obtained from Catha edulis Forsk. (Khat) in rats.
Topics: Alkaloids; Amphetamine; Animals; Appetite Depressants; Body Weight; Drug Tolerance; Eating; Phenylpropanolamine; Plants, Medicinal; Propiophenones; Rats | 1980 |
Effects of chronic phenylpropanolamine infusion and termination on body weight, food consumption and water consumption in rats.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Drinking; Eating; Male; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1994 |
Effects of phenylpropanolamine infusion and withdrawal on body weight and dietary composition in male and female rats.
Topics: Animals; Body Weight; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Dose-Response Relationship, Drug; Drinking; Eating; Energy Intake; Feeding Behavior; Female; Infusion Pumps; Male; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Sex Factors; Weight Gain | 1993 |
Tolerance does not develop to the suppressant effects of (-)-norpseudoephedrine on ingestive behavior in the rat.
Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Diuresis; Drinking Behavior; Drug Tolerance; Eating; Feeding Behavior; Male; Phenylpropanolamine; Rats; Rats, Sprague-Dawley | 1996 |
Three anorectic drugs: similar structures but different effects on brain and behavior.
Topics: Amphetamine; Animals; Appetite Depressants; Behavior; Blood Glucose; Body Weight; Brain; Dose-Response Relationship, Drug; Eating; Fenfluramine; Haplorhini; Humans; Hypothalamus; Mesencephalon; Models, Neurological; Obesity; Phenylpropanolamine; Rats; Receptors, Adrenergic; Self Stimulation | 1978 |
Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats.
Topics: Animals; Body Weight; Drinking; Eating; Male; Nicotine; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Weight Gain | 1992 |
Potential of chemical regulation of food intake and body weight of broiler breeder chicks.
Topics: Animal Feed; Animals; Body Weight; Chickens; Dietary Proteins; Eating; Female; Male; Monensin; Phenylpropanolamine; Random Allocation | 1990 |
Comparison of the effect of common decongestant agents and amphetamine on fighting behavior and weight change.
Topics: Aggression; Animals; Body Weight; Dextroamphetamine; Ephedrine; Mice; Phenylephrine; Phenylpropanolamine; Reference Values; Time Factors | 1988 |
The effects of phenylpropanolamine on food intake and body weight in the genetically obese (ob/ob) mouse.
Topics: Animals; Body Weight; Eating; Female; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Phenylpropanolamine | 1987 |
Effect of the khat alkaloid (+)norpseudoephedrine on uteroplacental blood flow in the guinea pig.
Topics: Animals; Appetite Depressants; Body Weight; Cardiac Output; Catha; Female; Fetus; Guinea Pigs; Hemodynamics; Male; Organ Size; Phenylpropanolamine; Placenta; Plant Extracts; Pregnancy; Regional Blood Flow; Uterus; Vascular Resistance | 1987 |
The effect of phenylpropanolamine and amphetamine on fighting behavior and weight change in mice.
Topics: Aggression; Animals; Body Weight; Dextroamphetamine; Mice; Phenylpropanolamine | 1987 |
Action of fenfluramine, phenylpropanolamine, phentermine and diethylpropion on acoustic startle in rats.
Topics: Acoustic Stimulation; Animals; Appetite Depressants; Body Weight; Diethylpropion; Drug Tolerance; Fenfluramine; Male; Phentermine; Phenylpropanolamine; Rats; Reflex, Startle | 1987 |
Weight loss induced by chronic phenylpropanolamine: anorexia and brown adipose tissue thermogenesis.
Topics: Adipose Tissue, Brown; Animals; Appetite Depressants; Body Composition; Body Temperature; Body Temperature Regulation; Body Weight; Drinking; Male; Phenylpropanolamine; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial.
Topics: Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Diet, Reducing; Double-Blind Method; Humans; Obesity; Phenylpropanolamine; Placebos; Random Allocation; Research Design; Surveys and Questionnaires | 1987 |
Effects of reserpine and adrenal demedullation on brown adipose tissue thermogenesis induced by dl-phenylpropanolamine.
Topics: Adipose Tissue, Brown; Adrenal Medulla; Animals; Body Temperature; Body Temperature Regulation; Body Weight; Drinking; Eating; Male; Phenylpropanolamine; Rats; Rats, Inbred Strains; Rectum; Reserpine | 1985 |